Researchers say PCSK9 inhibitors could reduce heart attacks, strokes and death but may be “cost-prohibitive” for widespread use in the United States.
Researchers say PCSK9 inhibitors could reduce heart attacks, strokes and death but may be “cost-prohibitive” for widespread use in the United States.
In a recent article in the Bristol Herald Courier, David Balto gives a great summary of the problems with the pharmacy benefit management industry, such
In a recent article at BenefitsPRO, Dan Cook talks about the movement to have employers “rise up and fight their own battles with the drug
“Today, one in four Americans who need prescription drugs struggle to afford them — one in four,” president Joe Biden. The last two administrations have
Lowcost Pharmacy Benefit Management
877.877.5711
info@arayarx.com
PO Box 460
Latham, NY 12110